Holdings
Farallon Capital Management, L.L.C.
As of Sep 30, 2026, Farallon Capital Management, L.L.C. reported 101 positions worth US$17.8B. Largest: Revolution Medicines, Inc., Warner Bros. Discovery, Inc. - Series A and Natera, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Revolution Medicines, Inc. | 13.4M | US$2.75B | −132K | Sep 30, 2026 |
| Warner Bros. Discovery, Inc. - Series A | 49.4M | US$1.53B | new | Sep 30, 2026 |
| Natera, Inc. | 2.6M | US$1.07B | +381K | Sep 30, 2026 |
| BridgeBio Pharma, Inc. | 14.2M | US$937M | +3.5M | Sep 30, 2026 |
| Protagonist Therapeutics, Inc. | 6.44M | US$907M | +89,000 | Sep 30, 2026 |
| Exelixis, Inc. | 14.7M | US$858M | +1.23M | Sep 30, 2026 |
| Roivant Sciences Ltd. | 21.7M | US$795M | +7.44M | Sep 30, 2026 |
| Roku, Inc. | 4.16M | US$633M | new | Sep 30, 2026 |
| Amazon.com, Inc. | 2.37M | US$590M | −265K | Sep 30, 2026 |
| GRAIL, Inc. | 4.07M | US$570M | −92,351 | Sep 30, 2026 |